Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-09BLTE144Hao-Yuan Chuang plan to sell securities of Belite Bio, Inc. under Form 144MEDIUM
Hao-Yuan Chuang filed Form 144 to notify SEC of plan to sell 100000 units of Belite Bio, Inc. securities around 2026-04-09, with aggregate market value of $17,873,000.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.25% of total outstanding units; ...
Mid CapBiotechnology
2026-04-09BLTE144Yu-Hsin Lin plan to sell securities of Belite Bio, Inc. under Form 144MEDIUM
Yu-Hsin Lin filed Form 144 to notify SEC of plan to sell 136000 units of Belite Bio, Inc. securities around 2026-04-09, with aggregate market value of $24,307,280.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.35% of total outstanding units; ...
Mid CapBiotechnology
2026-04-09BLTE144Wan Shan Chen plan to sell securities of Belite Bio, Inc under Form 144MEDIUM
Wan Shan Chen filed Form 144 to notify SEC of plan to sell 10196 units of Belite Bio, Inc securities around 2026-04-09, with aggregate market value of $2,220,250.00. The total outstanding units is 37514630.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Mid CapBiotechnology
2026-04-09BBIO144KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 plan to sell securities of BRIDGEBIO PHARMA INC under Form 144MEDIUM
KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 filed Form 144 to notify SEC of plan to sell 120000 units of BRIDGEBIO PHARMA INC securities around 2026-04-09, with aggregate market value of $8,896,800.00. The total outstanding units is 193862871.0. The amount planned to be sold represents 0.06% of total outstanding un...
Large CapBiotechnology
2026-04-09BELITE BIO, INC144Wan Shan Chen plan to sell securities of Belite Bio, Inc under Form 144DuplicateMEDIUM
Wan Shan Chen filed Form 144 to notify SEC of plan to sell 10196 units of Belite Bio, Inc securities around 2026-04-09, with aggregate market value of $2,220,250.00. The total outstanding units is 37514630.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Mid CapBiotechnology
2026-04-09BELITE BIO, INC144Hao-Yuan Chuang plan to sell securities of Belite Bio, Inc. under Form 144DuplicateMEDIUM
Hao-Yuan Chuang filed Form 144 to notify SEC of plan to sell 100000 units of Belite Bio, Inc. securities around 2026-04-09, with aggregate market value of $17,873,000.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.25% of total outstanding units; ...
Mid CapBiotechnology
2026-04-09DNTH144RYAN SAVITZ plan to sell securities of DIANTHUS THERAPEUTICS INC under Form 144MEDIUM
RYAN SAVITZ filed Form 144 to notify SEC of plan to sell 8224 units of DIANTHUS THERAPEUTICS INC securities around 2026-04-09, with aggregate market value of $719,435.52. The total outstanding units is 44471094.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past 3 m...
Mid CapBiotechnology
Sponsored
2026-04-09DNA144Kelly Jason R plan to sell securities of Ginkgo Bioworks Holdings, Inc. under Form 144MEDIUM
Kelly Jason R filed Form 144 to notify SEC of plan to sell 109767 units of Ginkgo Bioworks Holdings, Inc. securities around 2026-04-09, with aggregate market value of $702,201.45. The total outstanding units is 49941878.0. The amount planned to be sold represents 0.22% of total outstanding units; Recent transactions in...
Small CapBiotechnology
2026-04-09Ginkgo Bioworks Holdings, Inc.144Kelly Jason R plan to sell securities of Ginkgo Bioworks Holdings, Inc. under Form 144DuplicateMEDIUM
Kelly Jason R filed Form 144 to notify SEC of plan to sell 109767 units of Ginkgo Bioworks Holdings, Inc. securities around 2026-04-09, with aggregate market value of $702,201.45. The total outstanding units is 49941878.0. The amount planned to be sold represents 0.22% of total outstanding units; Recent transactions in...
Small CapBiotechnology
2026-04-09BridgeBio Pharma, Inc.144KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 plan to sell securities of BRIDGEBIO PHARMA INC under Form 144DuplicateMEDIUM
KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 filed Form 144 to notify SEC of plan to sell 120000 units of BRIDGEBIO PHARMA INC securities around 2026-04-09, with aggregate market value of $8,896,800.00. The total outstanding units is 193862871.0. The amount planned to be sold represents 0.06% of total outstanding un...
Large CapBiotechnology
2026-04-09BELITE BIO, INC144Yu-Hsin Lin plan to sell securities of Belite Bio, Inc. under Form 144DuplicateMEDIUM
Yu-Hsin Lin filed Form 144 to notify SEC of plan to sell 136000 units of Belite Bio, Inc. securities around 2026-04-09, with aggregate market value of $24,307,280.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.35% of total outstanding units; ...
Mid CapBiotechnology